SUBVENITE
These highlights do not include all the information needed to use SUBVENITE safely and effectively. See full prescribing information for SUBVENITE. SUBVENITE (lamotrigine) tablets USP, for oral use Initial U.S. Approval: 1994
7ad18b68-ba16-4810-9c3e-27fa970454e8
HUMAN PRESCRIPTION DRUG LABEL
May 14, 2021
OWP Pharmaceuticals, Inc.
DUNS: 079392532
Products 7
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LAMOTRIGINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
LAMOTRIGINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
LAMOTRIGINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
LAMOTRIGINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
LAMOTRIGINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
LAMOTRIGINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
LAMOTRIGINE
Product Details
FDA regulatory identification and product classification information